Sander De Bruyne

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

Sander De Bruyne, Nancy Van Damme, Peter Smeets et al. · British Journal of Cancer · 2012 · 118 citations · Full text

Medicine, Oncology, Radiology +17

Potentials and pitfalls of ChatGPT and natural-language artificial intelligence models for the understanding of laboratory medicine test results. An assessment by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group on Artificial Intelligence (WG-AI)

Janne Cadamuro, Federico Cabitza, Željko Debeljak et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2023 · 118 citations · Full text

Computing, Computer Science, Health Informatics +13

Application of Machine Learning in Chronic Kidney Disease: Current Status and Future Prospects

Charlotte Delrue, Sander De Bruyne, Marijn M. Speeckaert · Biomedicines · 2024 · 59 citations · Full text

Computing, Data Science, Nephrology +17

Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases

Jeroen Mertens, Sander De Bruyne, Nancy Van Damme et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 25 citations

Medicine, Molecular Medicine, Cellular Metabolism +14

A comprehensive survey of artificial intelligence adoption in European laboratory medicine: current utilization and prospects

Janne Cadamuro, Anna Carobene, Federico Cabitza et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2024 · 23 citations · Full text

Computing, Medical Education, Artificial Intelligence +9